Physician profile
Michelle Eng
NPI 1720128333
$404.67
in general payments reported to CMS, 2019-2025
7 companies · $90.09 in 2025
The $90.09 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.04 · 2022: $11.97 · 2023: $157 · 2024: $47.32 · 2025: $90.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44.61 · Education: $27.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44.61 |
| Education | $27.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Voco America INC. | $93.61 | 2019-2025 | Futurabond U, Grandio So, Admira Fusion X-Tra |
| 3m Company | $89.08 | 2019-2023 | 3m Relyx, 3m Filtek, Clinpro 5000 |
| Dentsply Sirona INC | $72.24 | 2019-2025 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Septodont INC. | $71.71 | 2023 | Bioroot Flow (Sample), Biodentine |
| Solventum Corporation | $32.67 | 2025 | Clinpro 5000, Filtek |
| Henry Schein, INC. | $27.03 | 2023 | |
| Kerr Corporation | $18.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Eng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.